4 ms·
It may not be fair math. The company may bet on 10 different things and just one pays off. It needs to pay off for the bad bets as well.
by thefounder 2y ago
It may not be fair math. The company may bet on 10 different things and just one pays off. It needs to pay off for the bad bets as well.
- gramie 2y ago> in line with recouping R&D and production costs That's the "recouping R&D" part.
- thefounder 2y agoAnd who invests in companies that merely recoup the R&D ?
- datavirtue 2y agoIt seems like a previous comment pointing out how investors actually fund new drug development seems to track with the loads of pharma startups working on one thing each. Run some stock screeners on your brokerage account. You have to work to generate a list without a pharma startup on it.
- s1artibartfast 2y agoA big part of this businesses model is because only large Pharma companies are equipped to handle the regulatory barriers and large enough to negotiate with the PBMs